Skip to main content

Search

Types

News (209)
Video Asset (21)

Showing 121 - 144 of 230 results

Previous| 1... 5 | 6 | 7 ...10 |Next

Active Surveillance for Kidney Cancer

Active Surveillance for Kidney Cancer

Johns Hopkins Urological Innovations

Johns Hopkins Urological Innovations

Big Data Helps Shape A New Model for Live Kidney Donation

Big Data Helps Shape A New Model for Live Kidney Donation

In Active Surveillance, Some Small Kidney Tumors Just Go Away

In Active Surveillance, Some Small Kidney Tumors Just Go Away

HOXB13 and AR-V7: Genetic Partners in Crime

HOXB13 and AR-V7: Genetic Partners in Crime

The DISSRM: Nearly a Decade of Patient-Specific Treatment

The DISSRM: Nearly a Decade of Patient-Specific Treatment

A Powerful Immunotherapy Mix for Bladder Cancer

A Powerful Immunotherapy Mix for Bladder Cancer

Neoadjuvant Chemotherapy And Upper Tract Urothelial Cancer

Neoadjuvant Chemotherapy And Upper Tract Urothelial Cancer

“Liquid Biopsy” and Personalized Treatment for Bladder Cancer

“Liquid Biopsy” and Personalized Treatment for Bladder Cancer

In Bladder Cancer, the Subtype Matters

In Bladder Cancer, the Subtype Matters

Remembering Donald S. Coffey

Remembering Donald S. Coffey

Identifying Genes through Discovery

Identifying Genes through Discovery

If You Have Lymph Node Metastases After Radical Prostatectomy, What Should You Do?

If You Have Lymph Node Metastases After Radical Prostatectomy, What Should You Do?

“We’ve Got a Team.”

“We’ve Got a Team.”

Not So Many Biopsies in Active Surveillance?

Not So Many Biopsies in Active Surveillance?

Could Inherited Gene Mutations Affect Men in Active Surveillance?

Could Inherited Gene Mutations Affect Men in Active Surveillance?

“Liquid Biopsy” for Advanced Prostate Cancer Spots Tiny Danger Signs Sooner

“Liquid Biopsy” for Advanced Prostate Cancer Spots Tiny Danger Signs Sooner

A Key Target in Aggressive Prostate Cancer May Lead to New Drug Development

A Key Target in Aggressive Prostate Cancer May Lead to New Drug Development

Combination Immunotherapy Combats AR-V7+ Prostate Cancer

Combination Immunotherapy Combats AR-V7+ Prostate Cancer

What’s the Best Way to Treat Localized, Gleason 9-10 Prostate Cancer?

What’s the Best Way to Treat Localized, Gleason 9-10 Prostate Cancer?

New Device Extracts CTCs From Blood

New Device Extracts CTCs From Blood

End-of-Radiation PSA and Intermediate- Risk Cancer

End-of-Radiation PSA and Intermediate- Risk Cancer

Prostate Cancer Therapy and the Gut Microbiome

Prostate Cancer Therapy and the Gut Microbiome

Could Some Intermediate- Risk Men Do Active Surveillance?

Could Some Intermediate- Risk Men Do Active Surveillance?

Showing 121 - 144 of 230 results

Previous| 1... 5 | 6 | 7 ...10 |Next

Connect with Johns Hopkins Medicine

Join Our Social Media Communities >

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Powered by BROADCASTMED